Procter & Gamble
Will begin construction of a $ 280 mil. worldwide health care R&D headquarters in 1992. Located on 253 acres in suburban Cincinnati, the facility is expected to open in 1995 and to employ about 1,000. P&G says its Norwich Eaton Pharmaceuticals unit will remain based in Norwich, N.Y.; however, the upstream prescription drug research and regulatory/medical affairs organizations now located in Norwich will move to the new center. Rich-Vicks facility in Shelton, Connecticut will close by late 1992. . . .
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth